Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Geriatrics & Gerontology International
|
April 1, 2025
Comparison of retroperitoneal laparoscopic radical nephroureterectomy outcomes in elderly patients based on the Geriatric 8 (G8) screening tool
Katsuya Hikita, Masashi Honda, Naru Shimizu, et al.
International Journal of Clinical Oncology
|
May 20, 2022
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Hideo Fukuhara, et al.
International Journal of Clinical Oncology
|
March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel
Takuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
Japanese Journal of Clinical Oncology
|
October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
Nutrition and Cancer
|
July 3, 2026
Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective Study
Ryutaro Shimizu, Shuichi Morizane, Noriya Yamaguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 30, 2022
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis
Ryoma Nishikawa, Makito Miyake, Shuichi Morizane, et al.
Japanese Journal of Clinical Oncology
|
October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortium
Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
Japanese Journal of Clinical Oncology
|
December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium
Hideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology
|
February 2, 2025
Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC
Yoichiro Tohi, Keita Kobayashi, Kei Daizumoto, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Geriatrics & Gerontology International
|
April 1, 2025
Comparison of retroperitoneal laparoscopic radical nephroureterectomy outcomes in elderly patients based on the Geriatric 8 (G8) screening tool
Katsuya Hikita, Masashi Honda, Naru Shimizu, et al.
International Journal of Clinical Oncology
|
May 20, 2022
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Hideo Fukuhara, et al.
International Journal of Clinical Oncology
|
March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel
Takuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
Japanese Journal of Clinical Oncology
|
October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
Nutrition and Cancer
|
July 3, 2026
Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective Study
Ryutaro Shimizu, Shuichi Morizane, Noriya Yamaguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 30, 2022
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis
Ryoma Nishikawa, Makito Miyake, Shuichi Morizane, et al.
Japanese Journal of Clinical Oncology
|
October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortium
Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
Japanese Journal of Clinical Oncology
|
December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium
Hideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology
|
February 2, 2025
Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC
Yoichiro Tohi, Keita Kobayashi, Kei Daizumoto, et al.
Page
of 4